REGENTIS BIOMATERIALS LTD. (RGNT)
About REGENTIS BIOMATERIALS LTD.
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$13.6M
- Total assets
- $7.6M
- Market cap
- $6.8M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $6.8M
- Shares outstanding
- 3.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 4, 2025
Regentis Biomaterials Ltd. (RGNT) Stock Price
- Reported a net loss of $13.6M.
- Trading 79% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review REGENTIS BIOMATERIALS LTD..
Write a review
News about REGENTIS BIOMATERIALS LTD.
News & sentiment via Polygon.io
Regentis Biomaterials Ltd.: frequently asked questions
Is Regentis Biomaterials Ltd. an American company?
Regentis Biomaterials Ltd. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is Regentis Biomaterials Ltd. publicly traded?
Yes — Regentis Biomaterials Ltd. is a publicly traded company. Its stock trades under the ticker symbol RGNT on the NYSE.
What does Regentis Biomaterials Ltd. do?
Regentis Biomaterials Ltd. is an American Medical Devices company in the Health & Beauty sector.
